VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 139 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $206,000 | -4.2% | 10,820 | -15.0% | 0.06% | -12.5% |
| Q1 2018 | $215,000 | -4.0% | 12,730 | -13.7% | 0.07% | -1.4% |
| Q4 2017 | $224,000 | -19.7% | 14,750 | -5.2% | 0.07% | -20.7% |
| Q3 2017 | $279,000 | -46.8% | 15,560 | -51.6% | 0.09% | -38.7% |
| Q2 2017 | $524,000 | -0.9% | 32,160 | -14.9% | 0.15% | +19.0% |
| Q1 2017 | $529,000 | -12.3% | 37,800 | 0.0% | 0.13% | -8.7% |
| Q4 2016 | $603,000 | -5.9% | 37,800 | -1.9% | 0.14% | -9.2% |
| Q3 2016 | $641,000 | – | 38,540 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,715,000 | $19,345,000 | 7.65% |
| Avoro Capital Advisors LLC | 2,124,593 | $23,965,000 | 6.23% |
| Asymmetry Capital Management, L.P. | 118,707 | $1,339,000 | 2.98% |
| ARMISTICE CAPITAL, LLC | 760,000 | $8,573,000 | 2.93% |
| Consonance Capital Management LP | 1,436,796 | $16,207,000 | 2.28% |
| Palo Alto Investors LP | 3,997,108 | $45,087,000 | 2.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,784,157 | $53,965,000 | 2.09% |
| PURA VIDA INVESTMENTS, LLC | 247,500 | $2,792,000 | 1.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,943,267 | $21,920,000 | 1.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 513,390 | $5,791,000 | 0.74% |